Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
Filetype[PDF-498.63 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 576.47 KB]
    Personal Author:
    MacNeil, Jessica R.; Medah, Isaïe; Koussoubé, Daouda; Novak, Ryan T.; Cohn, Amanda C.; Diomandé, Fabien V.K.; Yelbeogo, Denis; Kambou, Jean Ludovic; Tarbangdo, Tiga F.; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Hatcher, Cynthia; Vuong, Jeni; Mayer, Leonard W.; Djingarey, Mamoudou H.; Clark, Thomas A.; Messonnier, Nancy E.;
    Published Date:
    Mar 2014
    Source:
    Emerg Infect Dis. 20(3):394-399.
    Description:
    Multidrug- (MDR) and extensively drug-resistant tuberculosis (XDR TB) are commonly associated with Beijing strains. However, in KwaZulu-Natal, South Africa, which has among the highest incidence and mortality for MDR and XDR TB, data suggest that non...
    File Type:
    Filetype[PDF - 576.47 KB]
  2. Filetype[PDF - 576.47 KB]
    Personal Author:
    MacNeil, Jessica R.; Medah, Isaïe; Koussoubé, Daouda; Novak, Ryan T.; Cohn, Amanda C.; Diomandé, Fabien V.K.; Yelbeogo, Denis; Kambou, Jean Ludovic; Tarbangdo, Tiga F.; Ouédraogo-Traoré, Rasmata; Sangaré, Lassana; Hatcher, Cynthia; Vuong, Jeni; Mayer, Leonard W.; Djingarey, Mamoudou H.; Clark, Thomas A.; Messonnier, Nancy E.;
    Published Date:
    Mar 2014
    Source:
    Emerg Infect Dis. 20(3):394-399.
    Description:
    In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a n...
    File Type:
    Filetype[PDF - 576.47 KB]
  3. Filetype[PDF - 380.24 KB]
    Personal Author:
    Meyer, Sarah A.; Kambou, Jean Ludovic; Cohn, Amanda; Goodson, James L.; Flannery, Brendan; Medah, Isaïe; Messonnier, Nancy; Novak, Ryan; Diomande, Fabien; Djingarey, Mamoudou H.; Clark, Thomas A.; Yameogo, Issaka; Fall, Amadou; Wannemuehler, Kathleen;
    Published Date:
    Jan 28 2015
    Source:
    Vaccine. 33(12):1492-1498.
    Description:
    BackgroundA new serogroup A meningococcal conjugate vaccine (PsA-TT, MenAfriVac™) has been developed to combat devastating serogroup A Neisseria meningitis (MenA) epidemics in Africa. A mass immunization campaign targeting 1–29 year olds was cond...
    File Type:
    Filetype[PDF - 380.24 KB]
  4. Filetype[PDF - 171.94 KB]
    Personal Author:
    Terranella, Andrew; Cohn, Amanda; Clark, Thomas;
    Published Date:
    Sep 21 2011
    Source:
    Infect Drug Resist. 2011; 4:161-169.
    Description:
    Meningococcal conjugate vaccines have several advantages over polysaccharide vaccines, including the ability to induce greater antibody persistence, avidity, immunologic memory, and herd immunity. Since 1999, meningococcal conjugate vaccine programs ...
    File Type:
    Filetype[PDF - 171.94 KB]
  5. Filetype[PDF - 188.66 KB]
    Personal Author:
    Massenet, D.; Vohod, D.; Hamadicko, H.; Caugant, D.A.;
    Published Date:
    Nov 2011
    Source:
    Emerg Infect Dis. 17(11):2070-2072.
    File Type:
    Filetype[PDF - 188.66 KB]